Compare JKS & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JKS | OMCL |
|---|---|---|
| Founded | 2006 | 1992 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Computer Manufacturing |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2010 | 2000 |
| Metric | JKS | OMCL |
|---|---|---|
| Price | $25.32 | $33.46 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $23.88 | ★ $53.67 |
| AVG Volume (30 Days) | 464.4K | ★ 500.1K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 5.09% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $787,309,000.00 |
| Revenue This Year | N/A | $6.77 |
| Revenue Next Year | $37.42 | $5.22 |
| P/E Ratio | ★ N/A | $880.25 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $13.42 | $22.66 |
| 52 Week High | $31.88 | $51.84 |
| Indicator | JKS | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 50.76 | 34.40 |
| Support Level | $23.78 | $32.35 |
| Resistance Level | $26.06 | $33.87 |
| Average True Range (ATR) | 0.95 | 1.33 |
| MACD | 0.20 | 0.04 |
| Stochastic Oscillator | 69.98 | 17.30 |
JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific, and the Rest of the world.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.